AIZ vs FGEN · P/E 15, rev $3.45B vs rev $29.6M
Assurant Inc (AIZ) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the AIZ and FGEN stock pages for the full models.
Not investment advice.